Skip to main content
VCbacked
Log inGet Started

Deep Blue Biotech

Stowmarket, United Kingdom

Deep Blue Biotech uses synthetic biology to decarbonize chemicals, aiming for sustainable solutions to combat the climate crisis.

$800K raised
Nov 2024
Pre-Seed
BiotechnologyChemicalChemical Engineering

Top Investors

SFC CapitalCarbon13Sustainable VenturesOne Planet CapitalUndaunted The Greenhouse Accelerator

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Deep Blue Biotech

How much funding has Deep Blue Biotech raised?
Deep Blue Biotech has raised $800K in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2024.
Who are Deep Blue Biotech's investors?
Deep Blue Biotech's investors include SFC Capital, Carbon13, Sustainable Ventures, One Planet Capital, Undaunted The Greenhouse Accelerator.
Where is Deep Blue Biotech headquartered?
Deep Blue Biotech is headquartered in Stowmarket, United Kingdom.
What does Deep Blue Biotech do?
Deep Blue Biotech uses synthetic biology to decarbonize chemicals, aiming for sustainable solutions to combat the climate crisis.
What stage is Deep Blue Biotech at?
Deep Blue Biotech is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Deep Blue Biotech — Funding & Investors." VCBacked, November 4, 2024, https://www.vcbacked.co/company/deep-blue-biotech. Accessed June 4, 2026.
APA
VCBacked. (2024). Deep Blue Biotech — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/deep-blue-biotech
Wikipedia (cite web)
{{cite web |title=Deep Blue Biotech — Funding & Investors |url=https://www.vcbacked.co/company/deep-blue-biotech |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong